Cargando…

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family

Benzodiazepines are psychoactive drugs with anxiolytic, sedative, skeletal muscle relaxant and amnestic properties. Recently triazolo-benzodiazepines have been also described as potent and highly selective protein interaction inhibitors of bromodomain and extra-terminal (BET) proteins, a family of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filippakopoulos, Panagis, Picaud, Sarah, Fedorov, Oleg, Keller, Marco, Wrobel, Matthias, Morgenstern, Olaf, Bracher, Franz, Knapp, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748212/ https://www.ncbi.nlm.nih.gov/pubmed/22137933 http://dx.doi.org/10.1016/j.bmc.2011.10.080

Ejemplares similares

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding
por: Kempen, Herman J, et al.
Publicado: (2013)

Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010)

Bromodomains as therapeutic targets
por: Muller, Susanne, et al.
Publicado: (2011)

Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
por: Cipriano, Alessandra, et al.
Publicado: (2022)

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2011)

Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
por: Picaud, Sarah, et al.
Publicado: (2016)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014)

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
por: Lambert, Jean-Philippe, et al.
Publicado: (2019)

[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
por: Fedorov, Oleg, et al.
Publicado: (2013)

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012)

Molecular Basis of Histone Tail Recognition by Human TIP5 PHD Finger and Bromodomain of the Chromatin Remodeling Complex NoRC
por: Tallant, Cynthia, et al.
Publicado: (2015)

Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2013)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

Chemical probes and inhibitors of bromodomains outside the BET family
por: Moustakim, Moses, et al.
Publicado: (2016)

Dietary Compound Resveratrol Is a Pan-BET Bromodomain Inhibitor
por: Dutra, Luiz Antonio, et al.
Publicado: (2017)

7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes†
por: Huber, Kilian, et al.
Publicado: (2011)

Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability
por: Lori, Laura, et al.
Publicado: (2016)

Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

A chemical toolbox for the study of bromodomains and epigenetic signaling
por: Wu, Qin, et al.
Publicado: (2019)

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
por: Fedorov, Oleg, et al.
Publicado: (2011)

9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
por: Picaud, Sarah, et al.
Publicado: (2015)

Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
por: Fedorov, Oleg, et al.
Publicado: (2015)

The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
por: Taniguchi, Yasushi
Publicado: (2016)

BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Veppil Muralidharan, Somsundar, et al.
Publicado: (2017)

BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Muralidharan, Somsundar Veppil, et al.
Publicado: (2017)

SPOTing Acetyl-Lysine Dependent Interactions
por: Picaud, Sarah, et al.
Publicado: (2015)

A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation–π Interaction**
por: Rooney, Timothy P C, et al.
Publicado: (2014)

When are the BET factors the most sensitive to bromodomain inhibitors?
por: Khochbin, Saadi
Publicado: (2013)

BET bromodomain inhibitor (JQ1) and tumor angiogenesis
por: Bid, Hemant Kumar, et al.
Publicado: (2016)

Suppression of interferon β gene transcription by inhibitors of bromodomain and extra-terminal (BET) family members
por: Malik, Nazma, et al.
Publicado: (2015)

New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition
por: Baud, Matthias G. J., et al.
Publicado: (2015)

Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013)

Targeting BET bromodomain proteins in solid tumors
por: Sahai, Vaibhav, et al.
Publicado: (2016)

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
por: To, Kenneth K. W., et al.
Publicado: (2023)

Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
por: Fish, Paul V., et al.
Publicado: (2012)

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation
por: Meier, Julia C., et al.
Publicado: (2017)

Response and resistance to BET bromodomain inhibitors in triple negative breast cancer
por: Shu, Shaokun, et al.
Publicado: (2016)

Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off?
por: Groves, Ian J., et al.
Publicado: (2020)

BET Bromodomain Inhibitors and Pulmonary Arterial Hypertension: Take Care of the Heart
por: Piquereau, Jérôme, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lo47a9hudun5619l4c6evf2ln7